Epidemiology Research Core

Collection of biologic specimens, including blood, buccal cells, saliva and urine, from study participants and/or diagnosing hospitals including KCI and non-KCI facilities. 

Collection of medical records and abstracting of study-specific data, which are not available in the MDCSS registry.

Consultation and collaborative research expertise focused on study design, proposal development, IRB applications, and interpretation of population-based local and national SEER data. Consultation charges can be waived if other ERC services are budgeted

Identification of population-based control groups for case-control study designs via random digit dialing, Centers for Medicaid and Medicare Services (CMS) records, Department of Motor Vehicles (DMV) records, and other mechanisms.

Linkage of outside data sources to MCDSS data for the collection of patient demographics, treatment and survival data

Response to requests for population-based data requiring query of the MDCSS and/or the national SEER Limited-Use data files for descriptive analyses.

Rapid identification and ascertainment of eligible study participants, requiring review of all pathology reports indicating a cancer diagnosis at approximately 60 metropolitan area hospitals, clinics, pathology laboratories and radiation therapy facilities and rapid collection of patient demographic information. This speeds up case identification for population-based studies, with most cases identified within two to three months of diagnosis.

Regulatory oversight and research training support of study staff involved in studies in which participants are being contacted.

Collection of biologic tissue specimens, including tumor blocks and H&E stained slides and unstained slides from diagnosing hospitals including KCI and non-KCI facilities. Tumor Collection from KCI facilities is coordinated with the KCI Biorepository Core.

Collection of biologic specimens, including blood, buccal cells, saliva and urine, from study participants and/or diagnosing hospitals including KCI and non-KCI facilities. 

Collection of medical records and abstracting of study-specific data, which are not available in the MDCSS registry.

Consultation and collaborative research expertise focused on study design, proposal development, IRB applications, and interpretation of population-based local and national SEER data. Consultation charges can be waived if other ERC services are budgeted

Identification of population-based control groups for case-control study designs via random digit dialing, Centers for Medicaid and Medicare Services (CMS) records, Department of Motor Vehicles (DMV) records, and other mechanisms.

Linkage of outside data sources to MCDSS data for the collection of patient demographics, treatment and survival data

Response to requests for population-based data requiring query of the MDCSS and/or the national SEER Limited-Use data files for descriptive analyses.

Rapid identification and ascertainment of eligible study participants, requiring review of all pathology reports indicating a cancer diagnosis at approximately 60 metropolitan area hospitals, clinics, pathology laboratories and radiation therapy facilities and rapid collection of patient demographic information. This speeds up case identification for population-based studies, with most cases identified within two to three months of diagnosis.

Regulatory oversight and research training support of study staff involved in studies in which participants are being contacted.

Collection of biologic tissue specimens, including tumor blocks and H&E stained slides and unstained slides from diagnosing hospitals including KCI and non-KCI facilities. Tumor Collection from KCI facilities is coordinated with the KCI Biorepository Core.